VNDRIQ — Vendor Comparison
Aspirion vs DentalXChange
Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.
Aspirion
Revenue Cycle
Verification pending
DentalXChange
Revenue Cycle
Last verified: September 15, 2026
VNDRIQ Scores
63
Overall
43
Overall
Approval Tier
BAA Status
PHI Exposure Risk
AI Training Risk
HIPAA Risk Level
Review Frequency
Quarterly
Annual
Recommended Use
Management of complex claims, clinical denials, payment variance, and underpayment recovery.
—
Restrictions
Use is restricted to authorized revenue cycle and financial personnel; requires a signed Business Associate Agreement (BAA) and adherence to HITRUST-certified workflows.
—
Executive Summary
Aspirion
Revenue Cycle
Aspirion is classified as Approved With Restrictions with a BAA status of Yes, as a Business Associate providing RCM services to covered entities, Aspirion enters into BAAs to manage PHI.. PHI exposure is rated High and AI training risk is Medium. Management of complex claims, clinical denials, payment variance, and underpayment recovery.
50
Privacy
71
Governance
77
Healthcare
55
AI Risk
DentalXChange
Revenue Cycle
DentalXChange is classified as Conditional / Verify BAA with a BAA status of Verify Directly. PHI exposure is rated Critical and AI training risk is Low.
17
Privacy
51
Governance
32
Healthcare
70
AI Risk
Recommended For
Aspirion
Management of complex claims, clinical denials, payment variance, and underpayment recovery.
Organizations with established governance workflows
Multi-location healthcare groups needing standardized vendor status
DentalXChange
Organizations able to execute BAA prior to deployment
IT teams with capacity to verify data handling agreements
Governance Considerations
Aspirion
PHI exposure is elevated. Review data flow documentation.
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Use is restricted to authorized revenue cycle and financial personnel; requires a signed Business Associate Agreement (BAA) and adherence to HITRUST-certified workflows.
DentalXChange
BAA has not been confirmed. Execute BAA before processing PHI.
PHI exposure is elevated. Review data flow documentation.
Questions to Ask Before Approval
Has the vendor executed a Business Associate Agreement (BAA) with your organization?
Does the vendor use customer data to train AI models? Can you opt out?
Where is PHI stored, processed, and transmitted?
What data retention and deletion policies apply to your PHI?
Has the vendor undergone a third-party HIPAA or SOC 2 audit?
What is the vendor's incident response and breach notification process?
Does the vendor offer audit logging for PHI access?
What subprocessors have access to PHI through this vendor?
Request Vendor Evaluation
Get a structured risk assessment for any vendor.
Request Benchmark Report
Compare vendors across your full stack.
Book Governance Assessment
Talk to a VNDRIQ governance specialist.